Acta Med. 2002, 45: 75-78

https://doi.org/10.14712/18059694.2019.57

The Influence of Anticholinergic Drug and Oxime Selection on the Effectiveness of Antidotal Treatment Against Tabun-Induced Poisoning in Mice

Jiří Kassa

Purkyně Military Medical Academy, Department of Toxicology, Hradec Králové, Czech Republic

Received February 1, 2002
Accepted April 1, 2002

References

1. Bajgar J. Present view on toxidynamics of soman poisoning. Acta Med (Hradec Králové) 1996; 39:101-5.
2. Bajgar J, Fusek J, Vachek J. Treatment and prophylaxis against nerve agent poisoning. ASA Newslett 1994; 94(4):10-1.
3. Bajgar J, Patočka J, Herink J, Fusek J, Hrdina V. Effect of benactyzine, atropine and chlorpromazine on blood-brain barrier permeability in rats. Act Nerv Super 1978; 20:56-9.
4. Cabal J, Bajgar J. Tabun – návrat po padesáti letech. Chem Listy 1999; 93:27-31.
5. Clement JG. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat. Biochem Pharmacol 1982; 31:1283-7. <https://doi.org/10.1016/0006-2952(82)90017-X>
6. Clement JG, Shiloff JD, Gennings C. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning in mice. J Chromatogr 1987; 389:87-94.
7. Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317-31. <https://doi.org/10.1002/jat.2550140502>
8. Ellenwood EHJr, Nikaido AM, Gupta SK, Heatherly DG, Nishita JK. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics. J Pharmacol Exp Ther 1990; 255:1133-8.
9. Eto M. Organophosphorus pesticides: Organic and biological chemistry. Cleveland: CRC Press Inc, 1976:p 142.
10. Jokanovic M. Anticholinesterase activity and delayed neurotoxic effects of tabun in hens. Vojvosanit Pregl 1993; 50:451-6.
11. Jokanovic M, Maksimovic M, Kilibarda V, Jovanovic D, Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 1996; 85:35-9. <https://doi.org/10.1016/0378-4274(96)03634-X>
12. Kassa J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101:167-74. <https://doi.org/10.1016/0300-483X(95)03091-S>
13. Kassa J. Importance of cholinolytic drug selection for the efficacy of HI-6 against soman in rats. Toxicology 1997; 116:147-52. <https://doi.org/10.1016/S0300-483X(96)03537-8>
14. Kassa J, Cabal J, Bajgar J, Szinicz L. The choice: HI-6, pralidoxime or obidoxime against nerve agents? ASA Newslett 1997; 97(4):16-8.
15. Katayama S, Ishizaki F, Yamamura Y, Khoriyama T, Kito S. Effects of anticholinergic antiparkinsonic drugs on binding of muscarinic receptor subtypes in rat brain. Res Commun Chem Pathol Pharmacol 1990; 69:261-7.
16. Koplovitz I, Menton R, Matthews C, Shutz M, Nalls C, Kelly S. Dose-response effects of atropine and HI-6 treatment of organophosphorus poisoning in guinea pigs. Drug Chem Toxicol 1995; 18:119-36. <https://doi.org/10.3109/01480549509014316>
17. Koplovitz I, Stewart JR. A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin and VX in the rabbit. Toxicol Lett 1994; 70:169-79. <https://doi.org/10.1016/0378-4274(94)90121-X>
18. Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51-66. <https://doi.org/10.1016/0163-7258(93)90066-M>
19. Nakashima E, Ishizaki J, Takeda M, Matsushita R, Yokogawa K, Ichimura F. Pharmacodynamics of anticholinergic drugs and brain muscarinic receptor alteration in streptozotoxin diabetic rats. Biopharm Drug Dispos 1993; 14:673-8. <https://doi.org/10.1002/bdd.2510140804>
20. Ohtomi S, Takase M, Kumagai F. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Arm Ser 1996; 69:97-102.
21. Polhuijs M, Langenberg JP, Benschop H. New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol 1997; 146:156-61. <https://doi.org/10.1006/taap.1997.8243>
22. Puu G, Artursson E, Bucht G. Reactivation of nerve agent inhibited acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 1986; 35:1505-10. <https://doi.org/10.1016/0006-2952(86)90116-4>
23. Rousseaux CG, Dua AK. Pharmacology of HI-6, an H series oximes. Can J Physiol Pharmacol 1989; 67:1183-9. <https://doi.org/10.1139/y89-188>
24. Tallarida R, Murray R. Manual of pharmacological calculation with computer programs. New York, Springer-Verlag:1987:p.145.
25. Taylor P. Anticholinesterase agents. In: The pharmacological basis of therapeutics (Hardman JG, Lombird LE eds.). New York, McGraw Hill:1996:p.161-76.
26. Vachek J, Kassa J, Fusek J, Bajgar J. Novější způsoby léčby intoxikace organofosfáty. Sbor věd Prací VLA JEP (Hradec Králové) 1993; 116:67-95.
27. Worek F, Kirchner T, Szinicz L. Treatment of tabun poisoned guinea-pigs with atropine, Hlo-7 or HI-6: effect on respiratory and circulatory functions. Arch Toxicol 1994; 68:231-9. <https://doi.org/10.1007/s002040050062>
28. Worek F, Widmann R, Knopff O, Szinicz L. Reactivating potency of obidoxime, pralidoxime, HI-6 and Hlo-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 1998; 72:237-43. <https://doi.org/10.1007/s002040050495>
29. Yokogawa K, Nakashima E, Ishizaki J, Hasegawa M, Kido H, Ichimura F. Brain regional pharmacokinetics of biperiden in rats. Biopharm Drug Dispos 1992; 13:131-8. <https://doi.org/10.1002/bdd.2510130207>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive